The prodrug conversion pathway

Psilocybin itself is pharmacologically inert until alkaline phosphatases in the intestinal mucosa cleave the phosphate group, producing psilocin. This conversion is rapid — peak plasma psilocin typically occurs within 60–90 minutes of oral ingestion [1]

Carey et al. (2023)
Pharmacokinetics of oral psilocybin in healthy adults: a double-blind crossover study
Journal of Psychopharmacology · peer-reviewed
. The phosphate ester confers water solubility and oral bioavailability; the dephosphorylated form, psilocin, crosses the blood-brain barrier with high efficiency. First-pass hepatic metabolism is modest compared to many oral psychoactives, which partially explains the reliable dose-response relationship observed in controlled settings.

5-HT2A agonism and cortical disinhibition

Psilocin's primary mechanism is partial agonism at serotonin 5-HT2A receptors, which are expressed at highest density in cortical layer V pyramidal neurons [2]

Carhart-Harris & Goodwin (2017)
The therapeutic potential of psychedelic drugs: past, present and future
Neuropsychopharmacology · peer-reviewed
. Unlike classical serotonin reuptake inhibitors, which increase ambient serotonin broadly, psilocin directly activates a specific receptor subtype implicated in thalamocortical gating. The result is a paradoxical increase in cortical excitability paired with reduced thalamic filtering — effectively loosening the brain's predictive processing hierarchy.
Clinical note

5-HT2A agonism also explains the contraindication with lithium: both agents increase glutamatergic transmission, and the combination has been associated with seizure risk in case reports. This interaction is covered in depth in Cluster 04 — Interactions.

Default Mode Network suppression

Perhaps the most clinically significant downstream effect of 5-HT2A agonism is suppression of the Default Mode Network — the midline cortical system associated with self-referential thought, rumination, and rigid narrative identity [3]

Carhart-Harris et al. (2014)
The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
Frontiers in Human Neuroscience · peer-reviewed
. Resting-state fMRI studies using full-dose psilocybin show consistent DMN disintegration during peak drug effect, with post-session increases in between-network connectivity that persist for weeks [4]
Daws et al. (2022)
Increased global integration in the brain after psilocybin therapy for depression
Nature Medicine · peer-reviewed
. Whether microdosing produces measurable DMN changes remains an open empirical question — the sub-perceptual dose range may not produce the threshold activation needed for significant network disruption, though self-report data consistently describes reduced rumination.